AZ boosts vaccine capabilities with Omniose buy
AstraZeneca has bought a US biotech developing polysaccharide conjugate vaccines for bacterial infections, Omniose, after a three-year partnership.
Merck's rare tumour drug Pimjetmi claims FDA approval
Merck's Pimjetmi has been cleared in the US for tenosynovial giant cell tumour, adding a third FDA-approved treatment for the rare disorder.
Third Rock in $2bn drug-hunting pact with China's Funnel
New Chinese biotech Funnel has signed a $2bn-plus partnership with Third Rock Ventures, focused on using its AI platform to discover novel biologics.
UK's Oyster Tx rebrands and raises $60m for Alzheimer's R&D
UK start-up Oyster Therapeutics has raised $60m in first-round financing for its novel take on protein degraders, starting with tau in Alzheimer's.
Hims & Hers to offer unapproved peptides to customers
Telehealth firm Hims & Hers will soon start selling some unapproved peptides subject to the FDA's enforcement discretion policy announced last month.
Partner Content
The PM Awards aren’t just for agencies. They’re for the peop...
For decades, the PM Awards have been a fixture in the pharma and healthcare communications calendar
PMi Awards 2026: innovation, connection and a changing indus...
One of the things I enjoyed most about this year’s PM Society PMi Awards was the sheer breadth of the community in the room.
LEAP HR: Life Sciences Europe
Europe’s Only Industry-Specific Meeting Advancing HR Excellence in Life Sciences
Rational Based Drug Design Summit Europe
Driving Safer, Faster & More Efficient Discovery Across Europe
Evolution Summit 2027 to Convene Senior Clinical Development...
Westlake Village, CA: Marcus Evans today announced the Evolution Summit 2027, an invitation-only gathering of senior clinical trial executives
